Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine

Chronic HCV is a surreptitious disease currently affecting approximately 3% of the world's population that can lead to liver failure and cancer decades following initial infection. However, there are currently no vaccines available for the prevention of chronic HCV. From patients who acutely re...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Hum Vaccin Immunother
Autors principals: Latimer, Brian, Toporovski, Roberta, Yan, Jian, Pankhong, Panyupa, Morrow, Matthew P, Khan, Amir S, Sardesai, Niranjan Y, Welles, Seth L, Jacobson, Jeffrey M, Weiner, David B, Kutzler, Michele A
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4896772/
https://ncbi.nlm.nih.gov/pubmed/25424943
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.29590
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars